Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

9560	Companies
188851	Keywords
120589	Articles
100789	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 11/17/2025 at 14:00, 1 month 4 days ago

Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue
Jaguar Health, Inc. reports proof-of-concept trial shows crofelemer potential for MVID patients, financial results revealed, FDA meeting outcome, and upcoming investor webcast

Financial Results Crofelemer Investor Webcast Jaguar Health Inc. MVID
BRIEF

published on 11/14/2025 at 15:05, 1 month 7 days ago

Jaguar Health organisera une webdiffusion pour les investisseurs le 17 novembre 2025.

Rapport Financier Jaguar Health Magdalena Biosciences Webinaire Pour Les Investisseurs Médicaments Gastro-intestinaux
BRIEF

published on 11/14/2025 at 15:05, 1 month 7 days ago

Jaguar Health to Host Investor Webcast on November 17, 2025

Financial Report Investor Webcast Jaguar Health Magdalena Biosciences Gastrointestinal Medicines
PRESS RELEASE

published on 11/14/2025 at 15:00, 1 month 7 days ago

Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates
Jaguar Health, Inc. (NASDAQ:JAGX) to file Earnings Report on Form 10-Q for quarter ended September 30, 2025. Investor webcast on November 17, 2025 at 8:30 a.m. Eastern to review financials and provide corporate updates

Earnings Report Investor Webcast Jaguar Health Form 10-Q NASDAQ:JAGX
BRIEF

published on 11/13/2025 at 15:05, 1 month 8 days ago

Jaguar Health Highlights Promising Study Results for Crofelemer in Pediatric Intestinal Failure

Crofelemer Microvillus Inclusion Disease Clinical Trial Pediatric Intestinal Failure Parenteral Support
BRIEF

published on 11/13/2025 at 15:05, 1 month 8 days ago

Jaguar Health met en avant des résultats d'étude prometteurs concernant le crofélémère dans l'insuffisance intestinale pédiatrique

Crofelemer Essai Clinique Insuffisance Intestinale Chez L'enfant Maladie À Inclusions Microvillositaires Soutien Parentéral
PRESS RELEASE

published on 11/13/2025 at 15:00, 1 month 8 days ago

Jaguar Health Provides Recap of November 8, 2025 Presentation on Groundbreaking Results of Proof-of-Concept Study of Crofelemer for Treatment of Pediatric Intestinal Failure at NASPGHAN Annual Meeting
Crofelemer shows promising results in reducing total parenteral support for MVID patients, presented at NASPGHAN. Jaguar Health's investigation explores breakthrough benefits for pediatric patients with intestinal failure

Crofelemer Jaguar Health MVID Intestinal Failure NASPGHAN
BRIEF

published on 11/06/2025 at 15:05, 1 month 15 days ago

Jaguar Health Presents Promising Trial Results for Pediatric Intestinal Failure Treatment

Microvillus Inclusion Disease Short Bowel Syndrome Crofelemer Trial Pediatric Intestinal Failure Parenteral Support Reduction
BRIEF

published on 11/06/2025 at 15:05, 1 month 15 days ago

Jaguar Health présente des résultats d'essai prometteurs pour le traitement de l'insuffisance intestinale pédiatrique

Syndrome De L'intestin Court Insuffisance Intestinale Chez L'enfant Procès Crofelemer Réduction Du Soutien Parentéral Maladie À Inclusions Microvillositaires
PRESS RELEASE

published on 11/06/2025 at 15:00, 1 month 15 days ago

REMINDER: Initial Groundbreaking Results of Proof-of-Concept Study of Jaguar Health's Crofelemer for Treatment of Pediatric Intestinal Failure to be Presented November 8, 2025 at North American Society for Pediatric Gastroenterology, Hepatology and Nutrit
Ongoing trial of crofelemer in UAE shows reduction in parenteral support for pediatric intestinal failure patients. Breakthrough in MVID and SBS-IF treatment

Crofelemer MVID SBS-IF Intestinal Failure UAE Trial

Accesswire

Published on 12/20/2025 at 00:30, 1 day 19 hours ago

Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 1 day 22 hours ago

GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 2 days 1 hour ago

Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 5 hours ago

Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 2 days 6 hours ago

Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF

View all ACCESSWIRE

EQS Group

Published on 12/21/2025 at 08:55, 11 hours 32 minutes ago

Vantage Markets recognised for real-time threat intelligence collaboration with Trend Micro
Published on 12/20/2025 at 16:45, 1 day 3 hours ago

Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade
Published on 12/20/2025 at 10:05, 1 day 10 hours ago

FITUR 2026 highlights the strong synergies between Germany and Spain
Published on 12/19/2025 at 22:03, 1 day 22 hours ago

EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 1 day 22 hours ago

IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries

Les Echos

Published on 12/19/2025 at 21:57, 1 day 22 hours ago

Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 2 days 11 hours ago

Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 2 days 11 hours ago

Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 2 days 13 hours ago

EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 2 days 13 hours ago

EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION

View all LES ECHOS COMFI WIRE